Hadas Nicole R.

CIK 00016023961 companyCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001602396

Recent Transactions

50 trades

Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2024-05-13$1.26/sh−12,016→ 651,243 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2024-02-29$1.58/sh−5,974→ 663,259 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2024-02-27$1.52/sh−7,411→ 669,233 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2024-01-31+149,300→ 676,644 total
Award
Akebia Therapeutics, Inc.$AKBA
Stock Option (Right to buy)
2024-01-31+224,000→ 224,000 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2023-05-25$1.22/sh−63,186→ 524,344 total
Award
Akebia Therapeutics, Inc.$AKBA
Employee Stock Option (Right to buy)
2023-05-24+200,000→ 200,000 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2023-05-24+200,000→ 587,530 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2023-05-12+100,000→ 387,530 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2023-03-01$0.88/sh−5,333→ 295,231 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2023-03-01$0.88/sh−1,088→ 287,530 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2023-03-01$0.88/sh−6,613→ 288,618 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2023-02-27$0.81/sh−6,677→ 300,564 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2022-03-01$2.17/sh−1,078→ 304,241 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2022-03-01$2.17/sh−6,873→ 308,875 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2022-03-01$2.17/sh−6,556→ 302,319 total
Award
Akebia Therapeutics, Inc.$AKBA
Employee Stock Option (Right to buy)
2022-02-28+200,000→ 200,000 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2022-02-28$2.15/sh−6,555→ 265,748 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2022-02-28+50,000→ 315,748 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2021-04-01$3.40/sh−1,060→ 272,303 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2021-03-16+10,192→ 273,363 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2021-03-01$3.40/sh−7,976→ 263,171 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2021-03-01$3.40/sh−6,309→ 271,147 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2021-02-26+62,000→ 277,456 total
Award
Akebia Therapeutics, Inc.$AKBA
Employee Stock Option (Right to buy)
2021-02-26+110,000→ 110,000 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2020-02-28$8.70/sh−7,050→ 212,756 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2020-02-28+62,000→ 219,806 total
Award
Akebia Therapeutics, Inc.$AKBA
Stock Option (Right to buy)
2020-02-28+105,000→ 105,000 total
Disposition to Issuer
Akebia Therapeutics, Inc.$AKBA
Common Stock
2019-04-11$7.70/sh−11,929→ 154,806 total
Award
Akebia Therapeutics, Inc.$AKBA
Employee Stock Option (Right to buy)
2019-02-28+100,000→ 100,000 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2019-02-28+65,000→ 166,735 total
Tax Payment
Akebia Therapeutics, Inc.$AKBA
Common Stock
2018-12-12$8.94/sh−20,175→ 101,284 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2018-02-28+17,500→ 120,078 total
Award
Akebia Therapeutics, Inc.$AKBA
Employee Stock Option (Right to buy)
2018-02-28+25,000→ 25,000 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2017-10-02$19.95/sh−6,250→ 101,804 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2017-10-02$19.64/sh−1,553→ 108,054 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2017-07-03$14.26/sh−1,554→ 109,607 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2017-04-03$9.18/sh−1,556→ 109,856 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2017-02-21+28,500→ 111,412 total
Award
Akebia Therapeutics, Inc.$AKBA
Stock Option (Right to buy)
2017-02-21$10.14/sh+45,000→ 45,000 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2017-01-01$10.49/sh−1,810→ 82,912 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2016-10-01$8.95/sh−1,556→ 83,915 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2016-07-05$7.47/sh−1,557→ 85,471 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2016-04-04$9.41/sh−1,556→ 85,528 total
Award
Akebia Therapeutics, Inc.$AKBA
Stock Option (Right to Buy)
2016-02-22+34,300→ 34,300 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2016-02-22+22,500→ 87,084 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2016-01-04$12.28/sh−1,811→ 64,584 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2015-10-02$8.67/sh−1,484→ 65,260 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2015-07-02$9.54/sh−1,484→ 66,744 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2015-04-02$9.09/sh−1,483→ 76,093 total

Companies

Akebia Therapeutics, Inc.
VP General Counsel & Secretary
$AKBA

Recent Filings

Address

C/O AKEBIA THERAPEUTICS, INC. 245 FIRST STREET, SUITE 1100

CAMBRIDGE, MA, 02142

View on SEC.gov